TW200727922A - Solid dosage formulations of narcotic drugs having improved buccal adsorption - Google Patents

Solid dosage formulations of narcotic drugs having improved buccal adsorption

Info

Publication number: TW200727922A
Authority: TW; Taiwan
Prior art keywords: solid dosage; dosage formulations; narcotic drugs; adsorption; improved buccal
Prior art date: 2005-07-22

Application number

TW095126670A

Other languages

English (en)

Inventor

Federico Stroppolo

S Shahbaz Ardalan

Original Assignee

Alpex Pharma S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-22

Filing date

2006-07-21

Publication date

2007-08-01

2006-07-21 Application filed by Alpex Pharma S A filed Critical Alpex Pharma S A

2007-08-01 Publication of TW200727922A publication Critical patent/TW200727922A/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW095126670A 2005-07-22 2006-07-21 Solid dosage formulations of narcotic drugs having improved buccal adsorption TW200727922A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11/186,925 US20070020186A1 (en)	2005-07-22	2005-07-22	Solid dosage formulations of narcotic drugs having improved buccal adsorption

Publications (1)

Publication Number	Publication Date
TW200727922A true TW200727922A (en)	2007-08-01

Family

ID=37440618

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095126670A TW200727922A (en)	2005-07-22	2006-07-21	Solid dosage formulations of narcotic drugs having improved buccal adsorption

Country Status (26)

Country	Link
US (3)	US20070020186A1 (zh)
EP (1)	EP1906961B1 (zh)
JP (1)	JP5714797B2 (zh)
KR (1)	KR101326206B1 (zh)
CN (1)	CN101208091A (zh)
AU (1)	AU2006271870B2 (zh)
BR (1)	BRPI0613769A2 (zh)
CA (1)	CA2607360C (zh)
CY (1)	CY1117470T1 (zh)
DK (1)	DK1906961T3 (zh)
ES (1)	ES2569228T3 (zh)
HR (1)	HRP20160327T1 (zh)
HU (1)	HUE027354T2 (zh)
IL (1)	IL187387A (zh)
MA (1)	MA29744B1 (zh)
MX (1)	MX2007015480A (zh)
NO (1)	NO20080827L (zh)
NZ (1)	NZ563511A (zh)
PL (1)	PL1906961T3 (zh)
RS (1)	RS54670B1 (zh)
RU (1)	RU2408373C2 (zh)
SI (1)	SI1906961T1 (zh)
TW (1)	TW200727922A (zh)
UA (1)	UA90518C2 (zh)
WO (1)	WO2007009806A2 (zh)
ZA (1)	ZA200710406B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8252328B2 (en) *	2006-01-06	2012-08-28	Acelrx Pharmaceuticals, Inc.	Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) *	2006-01-06	2012-06-19	Acelrx Pharmaceuticals, Inc.	Small-volume oral transmucosal dosage forms
US9066847B2 (en) *	2007-01-05	2015-06-30	Aceirx Pharmaceuticals, Inc.	Storage and dispensing devices for administration of oral transmucosal dosage forms
US8357114B2 (en)	2006-01-06	2013-01-22	Acelrx Pharmaceuticals, Inc.	Drug dispensing device with flexible push rod
US8865743B2 (en)	2006-01-06	2014-10-21	Acelrx Pharmaceuticals, Inc.	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8535714B2 (en)	2006-01-06	2013-09-17	Acelrx Pharmaceuticals, Inc.	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en)	2006-01-06	2014-06-17	Acelrx Pharmaceuticals, Inc.	Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9289583B2 (en) *	2006-01-06	2016-03-22	Acelrx Pharmaceuticals, Inc.	Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en)	2007-01-05	2012-08-28	Acelrx Pharmaceuticals, Inc.	Bioadhesive drug formulations for oral transmucosal delivery
US20070260491A1 (en) *	2006-05-08	2007-11-08	Pamela Palmer	System for delivery and monitoring of administration of controlled substances
US20070299687A1 (en) *	2006-06-23	2007-12-27	Pamela Palmer	Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
MX337286B (es)	2007-05-25	2016-02-22	Indivior Uk Ltd	Formulaciones de transferencia sostenida de compuestos de risperidona.
US8945592B2 (en)	2008-11-21	2015-02-03	Acelrx Pharmaceuticals, Inc.	Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20110097401A1 (en) *	2009-06-12	2011-04-28	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
GB2481017B (en)	2010-06-08	2015-01-07	Rb Pharmaceuticals Ltd	Microparticle buprenorphine suspension
US9272044B2 (en)	2010-06-08	2016-03-01	Indivior Uk Limited	Injectable flowable composition buprenorphine
RU2476209C1 (ru) *	2012-02-29	2013-02-27	Станислав Анатольевич Кедик	Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов
BR112014024382B1 (pt)	2012-04-18	2022-08-09	SpecGx LLC	Composições farmacêuticas de contenção de abuso de liberação imediata e seu processo de preparação
MX362838B (es) *	2012-07-12	2019-02-19	SpecGx LLC	Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente.
GB201404139D0 (en)	2014-03-10	2014-04-23	Rb Pharmaceuticals Ltd	Sustained release buprenorphine solution formulations
MY187877A (en)	2014-12-23	2021-10-26	Acelrx Pharmaceuticals Inc	Systems, devices and methods for dispensing oral transmucosal dosage forms
EP3856160A4 (en)	2018-09-25	2022-07-06	SpecGx LLC	ANTI-ABUSE IMMEDIATE RELEASE CAPSULES DOSAGE FORMS

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5785989A (en)	1985-05-01	1998-07-28	University Utah Research Foundation	Compositions and methods of manufacturing of oral dissolvable medicaments
US5464632C1 (en)	1991-07-22	2001-02-20	Prographarm Lab	Rapidly disintegratable multiparticular tablet
JP3069458B2 (ja)	1992-01-29	2000-07-24	武田薬品工業株式会社	口腔内崩壊型錠剤およびその製造法
US5576014A (en)	1994-01-31	1996-11-19	Yamanouchi Pharmaceutical Co., Ltd	Intrabuccally dissolving compressed moldings and production process thereof
US5888534A (en)	1995-06-13	1999-03-30	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
US5624677A (en)	1995-06-13	1997-04-29	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
GB9517062D0 (en)	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions
KR20000022239A (ko) *	1996-07-11	2000-04-25	토마스 헤인	인돌 선택성 세로토닌 작용약을 함유한 내포 복합체
JP3770666B2 (ja) *	1996-09-20	2006-04-26	株式会社ティ・ティ・エス技術研究所	経粘膜吸収製剤用組成物
EP0839526A3 (en)	1996-10-31	1999-01-07	Takeda Chemical Industries, Ltd.	Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US6024981A (en)	1997-04-16	2000-02-15	Cima Labs Inc.	Rapidly dissolving robust dosage form
AU8977698A (en)	1997-07-25	1999-02-16	Elan Corporation, Plc	A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
US5869098A (en)	1997-08-20	1999-02-09	Fuisz Technologies Ltd.	Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US20030082107A1 (en) *	1997-10-01	2003-05-01	Dugger Harry A.	Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US6350470B1 (en)	1998-04-29	2002-02-26	Cima Labs Inc.	Effervescent drug delivery system for oral administration
US6200604B1 (en) *	1998-03-27	2001-03-13	Cima Labs Inc.	Sublingual buccal effervescent
US6974590B2 (en)	1998-03-27	2005-12-13	Cima Labs Inc.	Sublingual buccal effervescent
US6270790B1 (en)	1998-08-18	2001-08-07	Mxneil-Ppc, Inc.	Soft, convex shaped chewable tablets having reduced friability
US6680071B1 (en)	1999-03-03	2004-01-20	R. P. Scherer Technologies, Inc.	Opioid agonist in a fast dispersing dosage form
JP2000281589A (ja)	1999-03-26	2000-10-10	T T S Gijutsu Kenkyusho:Kk	経粘膜吸収助剤
US6210699B1 (en)	1999-04-01	2001-04-03	Watson Pharmaceuticals, Inc.	Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US6264981B1 (en)	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
US20030104041A1 (en) *	1999-12-16	2003-06-05	Tsung-Min Hsu	Transdermal and topical administration of drugs using basic permeation enhancers
US20020013331A1 (en) *	2000-06-26	2002-01-31	Williams Robert O.	Methods and compositions for treating pain of the mucous membrane
US6733781B2 (en)	2000-12-06	2004-05-11	Wyeth	Fast dissolving tablet
US20030215502A1 (en) *	2002-03-20	2003-11-20	Elan Pharma International Limited	Fast dissolving dosage forms having reduced friability
CA2479098A1 (en) *	2002-03-20	2003-09-25	Maree Therese Smith	Methods and compositions comprising nitric oxide donors and opioid analgesics
US20040253307A1 (en) *	2003-02-04	2004-12-16	Brian Hague	Sugar-free oral transmucosal solid dosage forms and uses thereof
US20040202698A1 (en)	2003-04-02	2004-10-14	The Procter & Gamble Company	Drug delivery systems comprising an encapsulated active ingredient
JP4739217B2 (ja) *	2003-05-07	2011-08-03	サムヤンコーポレイション	速く溶ける錠剤を製造するための高可塑性顆粒
ATE498395T1 (de) *	2003-12-31	2011-03-15	Cima Labs Inc	Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung

2005
- 2005-07-22 US US11/186,925 patent/US20070020186A1/en not_active Abandoned
2006
- 2006-07-21 CN CNA2006800232888A patent/CN101208091A/zh active Pending
- 2006-07-21 UA UAA200713973A patent/UA90518C2/ru unknown
- 2006-07-21 US US11/490,500 patent/US8574552B2/en active Active
- 2006-07-21 EP EP06776336.7A patent/EP1906961B1/en active Active
- 2006-07-21 CA CA2607360A patent/CA2607360C/en active Active
- 2006-07-21 NZ NZ563511A patent/NZ563511A/en not_active IP Right Cessation
- 2006-07-21 BR BRPI0613769-5A patent/BRPI0613769A2/pt not_active Application Discontinuation
- 2006-07-21 KR KR1020087000576A patent/KR101326206B1/ko active Active
- 2006-07-21 TW TW095126670A patent/TW200727922A/zh unknown
- 2006-07-21 SI SI200632040A patent/SI1906961T1/sl unknown
- 2006-07-21 AU AU2006271870A patent/AU2006271870B2/en not_active Ceased
- 2006-07-21 MX MX2007015480A patent/MX2007015480A/es active IP Right Grant
- 2006-07-21 HU HUE06776336A patent/HUE027354T2/en unknown
- 2006-07-21 PL PL06776336T patent/PL1906961T3/pl unknown
- 2006-07-21 RS RS20160214A patent/RS54670B1/en unknown
- 2006-07-21 RU RU2007149044/15A patent/RU2408373C2/ru active
- 2006-07-21 WO PCT/EP2006/007189 patent/WO2007009806A2/en active Application Filing
- 2006-07-21 JP JP2008521904A patent/JP5714797B2/ja active Active
- 2006-07-21 DK DK06776336.7T patent/DK1906961T3/en active
- 2006-07-21 ES ES06776336.7T patent/ES2569228T3/es active Active
2007
- 2007-11-15 IL IL187387A patent/IL187387A/en not_active IP Right Cessation
- 2007-11-30 ZA ZA200710406A patent/ZA200710406B/xx unknown
2008
- 2008-02-15 NO NO20080827A patent/NO20080827L/no not_active Application Discontinuation
- 2008-02-18 MA MA30659A patent/MA29744B1/fr unknown
2013
- 2013-09-04 US US14/017,642 patent/US10258693B2/en active Active
2016
- 2016-04-01 HR HRP20160327TT patent/HRP20160327T1/hr unknown
- 2016-04-26 CY CY20161100346T patent/CY1117470T1/el unknown

Also Published As

Publication number	Publication date
CY1117470T1 (el)	2017-04-26
NZ563511A (en)	2011-03-31
DK1906961T3 (en)	2016-05-02
US20070020186A1 (en)	2007-01-25
KR20080030608A (ko)	2008-04-04
WO2007009806A2 (en)	2007-01-25
IL187387A0 (en)	2008-02-09
US20070020187A1 (en)	2007-01-25
MX2007015480A (es)	2008-04-29
ZA200710406B (en)	2008-11-26
PL1906961T3 (pl)	2016-07-29
IL187387A (en)	2016-10-31
AU2006271870B2 (en)	2011-11-24
JP5714797B2 (ja)	2015-05-07
CN101208091A (zh)	2008-06-25
NO20080827L (no)	2008-02-15
SI1906961T1 (sl)	2016-09-30
US8574552B2 (en)	2013-11-05
EP1906961B1 (en)	2016-03-23
MA29744B1 (fr)	2008-09-01
AU2006271870A1 (en)	2007-01-25
US10258693B2 (en)	2019-04-16
ES2569228T3 (es)	2016-05-09
HUE027354T2 (en)	2016-09-28
RU2007149044A (ru)	2009-06-27
CA2607360A1 (en)	2007-01-25
CA2607360C (en)	2014-02-18
RU2408373C2 (ru)	2011-01-10
US20140018392A1 (en)	2014-01-16
KR101326206B1 (ko)	2013-11-08
EP1906961A2 (en)	2008-04-09
BRPI0613769A2 (pt)	2011-02-01
RS54670B1 (en)	2016-08-31
WO2007009806A3 (en)	2007-04-05
HRP20160327T1 (hr)	2016-05-20
JP2009502761A (ja)	2009-01-29
UA90518C2 (ru)	2010-05-11

Publication	Publication Date	Title
TW200727922A (en)	2007-08-01	Solid dosage formulations of narcotic drugs having improved buccal adsorption
IL175380A0 (en)	2008-04-13	Ophthalmologic pharmaceutical compositions containing a hydroxylamine compound
SG131857A1 (en)	2007-05-28	δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
MX2008002492A (es)	2008-04-03	Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
ZA200801991B (en)	2009-08-26	Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
TW200640861A (en)	2006-12-01	Amorphous lercanidipine hydrochloride
RS98704A (en)	2006-12-15	New pharmaceutical compositions containing flibanserin polymorpha
TW200718698A (en)	2007-05-16	Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
HK1096386A1 (en)	2007-06-01	Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200603810B (en)	2007-08-29	Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1096097A1 (en)	2007-05-25	Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1093986A1 (en)	2007-03-16	Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200402657B (en)	2004-10-14	Isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them.
TW200633717A (en)	2006-10-01	Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
ZA200606277B (en)	2007-04-25	Polysubstituted 1,1-pyridyloxycyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200606276B (en)	2007-12-27	Polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200501010B (en)	2005-08-30	BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
ZA200800833B (en)	2009-04-29	New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
SG110170A1 (en)	2005-04-28	New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
HK1123048A1 (en)	2009-06-05	Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
HK1079775A1 (en)	2006-04-13	New 4-oxo-4,6,7,8-tetrahydro-pyrrolo Ä1,2-AÜpyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200302392B (en)	2003-09-30	Indoline compounds, a process for their preparation and pharmaceutical compositions containing them.